164 related articles for article (PubMed ID: 27368955)
1. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
Morita C; Sakata VM; Rodriguez EE; Abdallah SF; Lavezzo MM; da Silva FT; Machado CG; Oyamada MK; Hirata CE; Yamamoto JH
Acta Ophthalmol; 2016 Dec; 94(8):e820-e821. PubMed ID: 27368955
[No Abstract] [Full Text] [Related]
2. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
[TBL] [Abstract][Full Text] [Related]
4. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
Lee GE; Lee BW; Rao NA; Fawzi AA
Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
[TBL] [Abstract][Full Text] [Related]
5. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
6. Angiographic and spectral domain optical coherence tomography features in case of Vogt-Koyanagi-Harada disease.
Nagpal MP; Bhatt KJ; Mehrotra NS; Goswami SD
Indian J Ophthalmol; 2015 Feb; 63(2):162-3. PubMed ID: 25827549
[No Abstract] [Full Text] [Related]
7. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
Kim M
Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
[No Abstract] [Full Text] [Related]
9. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
Li AS; Tang PH; Do DV
JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
[No Abstract] [Full Text] [Related]
10. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
13. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
14. Photoreceptor Cell Injury Starts in the Initial Stage of Vogt-Koyanagi-Harada Disease.
Zhu R; Zhang J; Qiao L; Zhang Y; Gu X; Yang L
Ocul Immunol Inflamm; 2018; 26(6):934-942. PubMed ID: 28323511
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
Tien MC; Teoh SC
Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
[No Abstract] [Full Text] [Related]
17. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
Montero JA; Sanchis ME; Fernandez-Munoz M
J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada disease masquerading as a lymphoproliferative process of the uvea.
Bhandari R; Dacey M; Schwartz S; Olson J; Quiroz-Mercado H; Mandava N; Oliver SC
Br J Ophthalmol; 2013 Nov; 97(11):1482-3, 1489-90. PubMed ID: 23913248
[No Abstract] [Full Text] [Related]
19. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
Parc C; Guenoun JM; Dhote R; Brézin A
Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
